- Conditions
- Gitelman Syndrome
- Interventions
- Hydrochlorothiazide
- Drug
- Lead sponsor
- Oregon Health and Science University
- Other
- Eligibility
- 21 Years to 65 Years
- Enrollment
- 8 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2013
- U.S. locations
- 1
- States / cities
- Portland, Oregon
Source: ClinicalTrials.gov public record
Updated Apr 4, 2019 · Synced May 21, 2026, 8:07 PM EDT